English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

How patenting informs VC investors – The Case of Biotechnology

MPS-Authors
/persons/resource/persons130171

Harhoff,  Dietmar
MPI for Innovation and Competition, Max Planck Society;

Locator
There are no locators available
Fulltext (public)
There are no public fulltexts available
Supplementary Material (public)
There is no public supplementary material available
Citation

Haeussler, C., Harhoff, D., & Mueller, E. (2014). How patenting informs VC investors – The Case of Biotechnology. Research Policy, 43(8), 1286-1298. doi:10.1016/j.respol.2014.03.012.


Cite as: http://hdl.handle.net/11858/00-001M-0000-0019-D3ED-E
Abstract
In the presence of asymmetric information, economic agents need to communicate their quality to investors and other parties. This paper investigates how information generated during the patenting process affects the ability of new ventures to attract VC financing. While much of the literature on information asymmetries focuses on patent applications, we argue that the entire examination process should be considered, including information that emerges in the course of patent examination and review. We test several hypotheses using a sample of British and German companies that seek venture capital. We find that the filing of patent applications is positively related to VC financing. Moreover, the examination process at the patent office generates valuable technological and commercial information via search reports, citations and opposition procedures which affect the likelihood of VC financing. Our results suggest that the patenting process supports investors in updating their expectations regarding the quality of new ventures.